Schedule 13G ownership disclosure
BIOTECH ACQUISITION COMPANY
Security class unavailable · CUSIP: G1125A108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 250,525
- Percent of class
- 1.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000769993-23-000258
- Form type
- SC 13G
- Filer
- GOLDMAN SACHS GROUP INC
- CIK
- CIK 886982
- Filed
- Feb 13, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership